Optimise your real estate to accelerate breakthroughs

Is your real estate powering your next life sciences discovery? Count on us to enhance your space for innovation, cost savings and resilience. 

Let’s talk

Benefits of enhancing your biopharma real estate strategy:

M&A cost savings

Identify best strategies to integrate and divest real estate assets as you transition whilst maintaining speed to market.

Free up capital through sale and leaseback

Unlock capital to reinvest into R&D, clinical trials or acquisitions, without having to relocate.

Sublease underutilised space

Manage risk of oversized real estate commitments and offset rental costs for spaces that are you are not fully utilising.

Meeting regulatory requirements across different jurisdictions

Ensure your facility adheres to strict country specific regulatory requirements whilst maintaining cost effectiveness.

Attract and retain top talent

Provide your people with access to state of the art facilities close to research institutes and biotech hubs where people can do their best work.

Crisis resilience and business continuity

Evaluate and mitigate risk of locations based on their resilience to potential disruptions such as pandemics, natural disasters and geopolitical tensions.

Why JLL?

How we've helped biopharma companies

Connect with an expert now

Portfolio strategy and facilities management for your biopharma

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.